Follow the Marinomed Biotech AG share price and the full insider trade history of the company, a publicly traded company based in Austria. Shares trade on AT AT, under the authority of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has logged 23 insider filings. Market capitalisation: €21.6m. The latest transaction was filed on 15 April 2026 (Purchase). Among the most active insiders: Unknown. The full history is free.
23
Insider Decl.
0
Thresholds
€201m
10 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Marinomed Biotech AG Buy (bullish), based on 1 analysts. Average price target: €50.00.
42Σ signal
Buys €201m· Sells
Fundamental score
Ranked 1,275 of 25,484 companies
79.1
score / 100
Value
74
Quality
85
FCF yld-5.7%
Earn yld94%
EV/EBITDA1.6x
ROE·
Gross mgn82%
Net mgn·
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.